Irrational prescription of surfactant replacement therapy in neonatal respiratory distress.

<h4>Purpose</h4>Respiratory distress is known as one of the leading causes of neonatal death. In recent decades, surfactant therapy has revolutionized respiratory failure. Since the implementation of the health system reform plan as well as the allocation of new financial resources for h...

Full description

Bibliographic Details
Main Authors: Nader Jahanmehr, Reyhane Izadi, Abbas Habibolahi, Setareh Yousefzadeh, Soheila Khodakarim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0268774
_version_ 1828268805056364544
author Nader Jahanmehr
Reyhane Izadi
Abbas Habibolahi
Setareh Yousefzadeh
Soheila Khodakarim
author_facet Nader Jahanmehr
Reyhane Izadi
Abbas Habibolahi
Setareh Yousefzadeh
Soheila Khodakarim
author_sort Nader Jahanmehr
collection DOAJ
description <h4>Purpose</h4>Respiratory distress is known as one of the leading causes of neonatal death. In recent decades, surfactant therapy has revolutionized respiratory failure. Since the implementation of the health system reform plan as well as the allocation of new financial resources for health system in Iran, the rate of irrational prescription has increased and prescription of surfactant for neonates, has raised unexpectedly, which is thought to be due to irrational prescriptions partly. The present study aimed to determine the rate of irrational prescription of surfactant for neonates with respiratory distress.<h4>Methods</h4>This research was a cross-sectional descriptive study, which was conducted retrospectively. In the current study, determining the rate of irrational prescription was done in terms of the surfactant prescription guideline. Finally, the medical data of 846 neonates who underwent surfactant therapy in Iran in 2018, were extracted from the information system of the Ministry of Health and the neonatal medical records.<h4>Results</h4>The results show that drug selection index, dose index, and time index were irrational for 14.30%, 27.42%, and 1.06% of neonates, respectively. Moreover, the total index of drug prescription, which is a combination of the above-mentioned three components, was found to be irrational for 31.47% of neonates.<h4>Conclusions</h4>The results of the present study are considered as a warning to providers and decision makers in the field of neonatal health to reduce irrational prescriptions of surfactant for neonates. This study suggests the use of educational interventions in order to reduce irrational prescriptions due to drug selection as well as the use of computer alert approaches in order to reduce irrational prescriptions due to wrong dose.
first_indexed 2024-04-13T05:23:15Z
format Article
id doaj.art-c505d2ea9a55473b80d101f4e99216d7
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T05:23:15Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c505d2ea9a55473b80d101f4e99216d72022-12-22T03:00:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01176e026877410.1371/journal.pone.0268774Irrational prescription of surfactant replacement therapy in neonatal respiratory distress.Nader JahanmehrReyhane IzadiAbbas HabibolahiSetareh YousefzadehSoheila Khodakarim<h4>Purpose</h4>Respiratory distress is known as one of the leading causes of neonatal death. In recent decades, surfactant therapy has revolutionized respiratory failure. Since the implementation of the health system reform plan as well as the allocation of new financial resources for health system in Iran, the rate of irrational prescription has increased and prescription of surfactant for neonates, has raised unexpectedly, which is thought to be due to irrational prescriptions partly. The present study aimed to determine the rate of irrational prescription of surfactant for neonates with respiratory distress.<h4>Methods</h4>This research was a cross-sectional descriptive study, which was conducted retrospectively. In the current study, determining the rate of irrational prescription was done in terms of the surfactant prescription guideline. Finally, the medical data of 846 neonates who underwent surfactant therapy in Iran in 2018, were extracted from the information system of the Ministry of Health and the neonatal medical records.<h4>Results</h4>The results show that drug selection index, dose index, and time index were irrational for 14.30%, 27.42%, and 1.06% of neonates, respectively. Moreover, the total index of drug prescription, which is a combination of the above-mentioned three components, was found to be irrational for 31.47% of neonates.<h4>Conclusions</h4>The results of the present study are considered as a warning to providers and decision makers in the field of neonatal health to reduce irrational prescriptions of surfactant for neonates. This study suggests the use of educational interventions in order to reduce irrational prescriptions due to drug selection as well as the use of computer alert approaches in order to reduce irrational prescriptions due to wrong dose.https://doi.org/10.1371/journal.pone.0268774
spellingShingle Nader Jahanmehr
Reyhane Izadi
Abbas Habibolahi
Setareh Yousefzadeh
Soheila Khodakarim
Irrational prescription of surfactant replacement therapy in neonatal respiratory distress.
PLoS ONE
title Irrational prescription of surfactant replacement therapy in neonatal respiratory distress.
title_full Irrational prescription of surfactant replacement therapy in neonatal respiratory distress.
title_fullStr Irrational prescription of surfactant replacement therapy in neonatal respiratory distress.
title_full_unstemmed Irrational prescription of surfactant replacement therapy in neonatal respiratory distress.
title_short Irrational prescription of surfactant replacement therapy in neonatal respiratory distress.
title_sort irrational prescription of surfactant replacement therapy in neonatal respiratory distress
url https://doi.org/10.1371/journal.pone.0268774
work_keys_str_mv AT naderjahanmehr irrationalprescriptionofsurfactantreplacementtherapyinneonatalrespiratorydistress
AT reyhaneizadi irrationalprescriptionofsurfactantreplacementtherapyinneonatalrespiratorydistress
AT abbashabibolahi irrationalprescriptionofsurfactantreplacementtherapyinneonatalrespiratorydistress
AT setarehyousefzadeh irrationalprescriptionofsurfactantreplacementtherapyinneonatalrespiratorydistress
AT soheilakhodakarim irrationalprescriptionofsurfactantreplacementtherapyinneonatalrespiratorydistress